Castration-resistant prostate cancer (CRPC)

Clinical trials for Castration-resistant prostate cancer (CRPC) explained in plain language.

Never miss a new study

Get alerted when new Castration-resistant prostate cancer (CRPC) trials appear

Sign up with your email to follow new studies for Castration-resistant prostate cancer (CRPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Terminated 1

Old drug, new hope: niclosamide combo targets resistant prostate cancer

Disease control Not yet recruiting

This early-stage trial tests whether adding CP-PCA07 (a form of niclosamide, a drug used for tapeworm infections) to the standard drug enzalutamide can safely help men with castration-resistant prostate cancer that has stopped responding to treatment. The study involves 18 men an…

Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

Phase 1 • Sponsor: Hyundai Bioscience Co., Ltd. • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Castration-resistant prostate cancer (CRPC)

Get alerted when new Castration-resistant prostate cancer (CRPC) trials appear

Old drug, new hope: niclosamide combo targets resistant prostate cancer